Clinical Trials Directory

Trials / Completed

CompletedNCT05638048

Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
270 (actual)
Sponsor
Junyan Zhao · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

In this study, color Doppler ultrasound diagnostic instrument and electronic grip device were used to determine the best grip strength of patients with tumor PICC catheterization, formulate precise and standardized grip strength training guidance for them, provide personalized functional exercise health education, and observe the impact of precise grip strength training guidance on Peripheral central venous catheter-associated thrombosis. To provide a reference for clinical prevention of Peripheral central venous catheter-associated thrombosis in the future.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPrecision grip trainingFirst determine patients for holding the ball movement should reach the effective blood flow velocity and best duration - relaxation, and USES the electronic grips and color doppler ultrasonic diagnostic apparatus, for individual patients to choose the best grip the efforts and training, to form the best grip the training plan, and observe the scheme for Peripheral central venous catheter-associated thrombosis prevention effect.
BEHAVIORALUse maximum strength grip trainingPatients were routinely implanted with PICC, and on the basis of health education in the control group, the best continuous-relaxation time, frequency and maximum grip strength of patients were used for grip strength training.
BEHAVIORALHealth education on routine grip strength trainingPatients were routinely implanted with PICC and received routine health education. The content of health education included face-to-face language explanation of the whole process of catheter knowledge, issuing catheter maintenance manual, issuing ordinary grip ball and telling how to use it, and follow-up.

Timeline

Start date
2022-07-10
Primary completion
2022-12-31
Completion
2023-01-10
First posted
2022-12-06
Last updated
2023-02-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05638048. Inclusion in this directory is not an endorsement.